| Name | Title | Contact Details |
|---|
Climb Bio, Inc. is a clinical-stage biotechnology company based in Wellesley Hills, Massachusetts. Founded in 2018 and formerly known as Eliem Therapeutics, Climb Bio focuses on developing innovative therapies for immune-mediated diseases. The company emphasizes building strong relationships to gain insights and create effective medicines aimed at improving the quality of life for patients. Climb Bios product pipeline includes Budoprutug, an anti-CD19 monoclonal antibody in various stages of development for B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody in preclinical development for IgA Nephropathy. The company is committed to advancing life sciences through innovative research and clinical trials, with a dedicated team led by CEO Aoife Brennan.
LSP Products Group is a Carson City, NV-based company in the Business Services sector.
Leizure Associates Inc is a Baltimore, MD-based company in the Business Services sector.
Odyssey Information Services is a Plano, TX-based company in the Business Services sector.
Thinkbox National Marketing is a Vancouver, BC-based company in the Business Services sector.